Replies to post #126037 on Biotech Values

[jb_118]

My take is it's either something major, or something unclear and they have lost confidence in their interpretation of FDA communications with them

It's been a while, but I recall Bill Marth saying on a cc that they basically asked the FDA to make an official response to them, the result of which was the CRL. Anybody else remember that?